Machine Learning

The education giant posted a 45% profit jump driven by new business lines and e-commerce, signaling its strategic transformation is a resounding success.

Parade Technologies posts lower Q1 profits despite a flurry of industry-first chip launches for AI data centers, automotive, and next-gen notebooks.

A new powerhouse residency program backed by Silicon Valley elite launches near Stanford to turn academic science into fundable healthcare companies.

Winning Adobe's top partner award for a third straight year, Adswerve combines strategic talent acquisition with deep technical mastery to redefine market leadership.

The diabetes tech firm posted a 57% revenue jump and lifted its 2026 outlook, but a sequential drop in new users raises questions for investors.

Garnering top awards for value and support, STRATAFOLIO's success highlights a move towards user-validated efficiency and a new AI-driven future for CRE.

Remix Therapeutics' first-in-class drug REM-422 targets a rare cancer at its genetic source, with pivotal data set for a major oncology conference.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

Akima's Pinnacle Solutions will deliver virtual reality training systems for the USMC's ACV fleet, aiming to boost technician skill and operational readiness.

A novel drug that targets the cellular environment of the MYC cancer protein, not the protein itself, shows major promise in preclinical studies.

As autonomous AI agents create new security risks, Operant AI's CodeInjectionGuard offers a runtime defense to stop attacks that static analysis can't see.

nuVizz Holding is funding a stealth AI firm to tackle a major software gap, moving beyond generic AI to deliver deeply customized logistics solutions.

TechSmith launches a new Camtasia app for Zoom, using AI to transform raw meeting recordings into professional-quality videos in minutes.

As GPS fails in modern warzones, one company's software-only solution allows drones to navigate and target without it, changing the face of conflict.

A new partnership aims to create more sustainable, resilient, and beautiful flowers using CRISPR, revolutionizing the multi-billion-dollar plant market.

Dizal to unveil late-breaking ZEGFROVY data for NSCLC, plus new findings for drugs tackling resistance and boosting immunotherapy at ASCO 2026.

The new Molecule Search platform unifies chemical and biological data, aiming to accelerate drug discovery in an increasingly competitive, AI-driven market.

As COVID revenues fall, BioNTech bets its future on a robust oncology pipeline. The upcoming Q1 2026 report will reveal the financial health of this pivot.

Sion Power's new 500 Wh/kg lithium-metal cells promise to revolutionize drone warfare, dramatically extending flight times and boosting US supply chain security.

Celebrating its 1,000th fellow, a visionary program empowers women in STEM to drive change, from cancer tech to national policy, in their home countries.